MAYLOTRA Trademark

Trademark Overview

On Tuesday, June 6, 2017, a trademark application was filed for MAYLOTRA with the United States Patent and Trademark Office. The USPTO has given the MAYLOTRA trademark a serial number of 87476958. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 14, 2020. This trademark is owned by Alkermes Pharma Ireland Limited. The MAYLOTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurologic disorders; Pharmaceutical preparations for the treatment of multiple sclerosis
maylotra

General Information

Serial Number87476958
Word MarkMAYLOTRA
Filing DateTuesday, June 6, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 14, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurologic disorders; Pharmaceutical preparations for the treatment of multiple sclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDUBLIN
IE
Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDUBLIN
IE

Trademark Events

Event DateEvent Description
Monday, December 14, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 14, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 13, 2020EXTENSION 5 GRANTED
Wednesday, April 8, 2020EXTENSION 5 FILED
Monday, April 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Tuesday, October 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 11, 2019EXTENSION 4 GRANTED
Friday, October 11, 2019EXTENSION 4 FILED
Friday, October 11, 2019TEAS EXTENSION RECEIVED
Saturday, February 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 21, 2019EXTENSION 3 GRANTED
Thursday, February 21, 2019EXTENSION 3 FILED
Thursday, February 21, 2019TEAS EXTENSION RECEIVED
Tuesday, October 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 26, 2018EXTENSION 2 GRANTED
Friday, October 26, 2018EXTENSION 2 FILED
Friday, October 26, 2018TEAS EXTENSION RECEIVED
Tuesday, March 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 9, 2018EXTENSION 1 GRANTED
Friday, March 9, 2018EXTENSION 1 FILED
Friday, March 9, 2018TEAS EXTENSION RECEIVED
Tuesday, November 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 31, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 21, 2017ASSIGNED TO EXAMINER
Tuesday, June 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 9, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

maylotra pharmaceutical treatment preparations sclerosis multiple neurologic disorders